TY  - RPRT
TI  - Development and validation of NAD+ metabolism-related gene signature in prognosis prediction ofhepatocellular carcinoma
AU  - Du, Y.
PY  - 2023
DO  - 10.1101/2023.06.25.546472
UR  - https://www.biorxiv.org/content/10.1101/2023.06.25.546472v1
ID  - 10.1101/2023.06.25.546472
ER  -